Selectively bred lines of rats differ in social interaction and hippocampal 5-HT(1A) receptor function: A link between anxiety and depression?

Pharmacology Biochemistry and Behavior

Volumn 59, Issue 4, 1998, Pages 787-792

  Gonzalez, Luis E ^a   File, Sandra E ^a   Overstreet, David H ^b  

^a GUY S HOSPITAL   (United Kingdom)

^b UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

Author keywords

5 HT(1A) receptors; Anxiety; Depression; Hippocampus; Social interaction

Indexed keywords

2 DIPROPYLAMINO 8 HYDROXYTETRALIN; N [2 [4 (2 METHOXYPHENYL) 1 PIPERAZINYL]ETHYL] N (2 PYRIDYL)CYCLOHEXANECARBOXAMIDE; POSTSYNAPTIC RECEPTOR; SEROTONIN 1A RECEPTOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANXIETY; ARTICLE; CONTROLLED STUDY; DEPRESSION; DISEASE PREDISPOSITION; HIPPOCAMPUS; HYPOTHERMIA; MAZE TEST; NONHUMAN; PRIORITY JOURNAL; RAT; SEROTONIN RELEASE; SEROTONINERGIC SYSTEM; SOCIAL INTERACTION;

8-HYDROXY-2-(DI-N-PROPYLAMINO)TETRALIN; ANIMALS; ANXIETY; DEPRESSIVE DISORDER; HIPPOCAMPUS; INTERPERSONAL RELATIONS; MOTOR ACTIVITY; PIPERAZINES; PYRIDINES; RATS; RATS, INBRED STRAINS; RECEPTORS, SEROTONIN; SEROTONIN AGONISTS; SEROTONIN ANTAGONISTS; SPECIES SPECIFICITY; STEREOTAXIC TECHNIQUES;

ANIMALIA;

EID: 0032052201     PISSN: 00913057     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0091-3057(97)00525-X     Document Type: Article

References (26)

1. Angst J., Vollrath M., Merikangas K., Ernst C. Comorbidity of anxiety and depression in the Zurich cohort study of young adults. Maser J. D., Cloninger C. R. Comorbidity of mood and anxiety disorders. 1990;123-137 American Psychiatric Press, Washington, DC.
2. Chaouloff F., Castanon N., Mormede P. Paradoxical differences in animal models of anxiety among the Roman rat lines. Neurosci. Lett. 182:1994;217-221.
3. 1A receptor agonist. Recent developments and controversial issues Psychopharmacology (Berlin). 121:1995;1-26.
4. 1A receptor antagonist. Psychopharmacology (Berlin). 119:1995;41-54.
5. File S. E. The use of social interaction as a method for detecting anxiolytic activity of chlordiazepoxide-like drugs. J. Neurosci. Methods. 2:1980;219-238.
6. File S. E. Behavioural detection of anxiolytic action. Elliott J. M., Heal D. J., Marsden C. A. Experimental approaches to anxiety and depression. 1992;25-44 John Wiley, London.
7. File S. E. The interplay of learning and anxiety in the elevated plus-maze. Behav. Brain Res. 58:1993;199-202.
8. File S. E., Hyde J. R. G. A test of anxiety that distinguishes between the actions of benzodiazepines and those of other minor tranquillisers and of stimulants. Pharmacol. Biochem. Behav. 11:1979;65-69.
9. File S. E., Johnston A. L. Chronic treatment with imipramine has no anxiolytic action and does not reverse the effects of three anxiogenic compounds in a test of anxiety in the rat. Neuropsychobiology. 17:1987;187-192.
10. 1A receptor modulation of anxiety in two ethological animal tests. J. Neurosci. 16:1996;4810-4815.
11. 1A and benzodiazepine receptors in the basolateral amygdala modulate anxiety in the social interaction test, but not in the elevated plus-maze. Brain Res. 732:1996;145-153.
12. 1A receptor regulation. Neuropsychopharmacology. 4:1991;131-144.
13. Janowsky D. S., Overstreet D. H. Anti-immobility effects of fluoxetine and desipramine in rats selectively bred for high sensitivity to 8-OH-DPAT. 26th Annual Meeting of the Society for Neuroscience:1996;16-21. Washington, DC, November ;
14. Johnston A. L., File S. E. Profiles of antipanic compounds, triazolobenzodiazepines and phenelzine, in two animal tests of anxiety. Psychiatr. Res. 25:1988;81-90.
15. Kelly J. P., Leonard B. E. The effects of tianeptine and sertraline in three animal models of depression. Neuropharmacology. 33:1994;1011-1016.
16. 2A receptor and 5-HT transporter binding in grouped and isolated Roman RHA and RLA rats. Relationships with behaviours in two models of anxiety Psychopharmacology (Berlin). 121:1995;385-395.
17. 1A receptor responsivity in anxiety disorders and depression. Prog. Neuropsychopharmacol. Biol. Psychiatry. 15:1991;723-733.
18. Lightowler S., Kennett G. A., Williamson I. J. R., Blackburn T. P., Tulloch I. F. Anxiolytic-like effect of paroxetine in a rat social interaction test. Pharmacol. Biochem. Behav. 49:1994;281-285.
19. Lister R. G. Ethologically based animal models of anxiety disorders. File S. E. Psychopharmacology of anxiolytics and antidepressants. 1991;155-185 Pergamon Press Inc, New York.
20. Maser J. D., Cloninger C. R. Comorbidity of mood and anxiety disorders. 1:1990;American Psychiatric Press, Washington, DC.
21. Merikangas K. R. Comorbidity for anxiety and depression. Review of family and genetic studies Maser J. D., Cloninger C. R. Comorbidity of mood and anxiety disorders. 1990;331-348 American Psychiatric Press, Washington DC.
22. 1A sensitivity in rats. Psychiatr. Genet. 4:1994;57-62.
23. Overstreet D. H., Rezvani A. H., Knapp D. J., Crew F. T., Janowsky D. S. Further selection of rat lines differing in 5-HT-1A receptor sensitivity. Behavioral and functional correlates Psychiatr. Genet. 6:1996;107-117.
24. Pellow S., Chopin P. H., File S. E., Briley M. Validation of open:closed arm entries in an elevated plus-maze as a measure of anxiety in the rat. J. Neurosci. Methods. 14:1985;149-167.
25. Pellow S., File S. E. Can anti-panic drugs antagonise the anxiety produced in the rat by drugs acting at the GABA-benzodiazepine receptor complex? Neuropsychobiology. 17:1987;60-65.
26. Treit D., Menard J., Royan C. Anxiogenic stimuli in the elevated plus-maze. Pharmacol. Biochem. Behav. 44:1993;463-469.